Insider Transactions in Q2 2023 at Health Catalyst, Inc. (HCAT)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2023
|
John A Kane |
BUY
Grant, award, or other acquisition
|
Direct |
22,553
+9.61%
|
-
|
|
Jun 14
2023
|
Julie Larson Green |
BUY
Grant, award, or other acquisition
|
Direct |
17,641
+17.25%
|
-
|
|
Jun 14
2023
|
Anita Pramoda |
BUY
Grant, award, or other acquisition
|
Direct |
18,311
+24.58%
|
-
|
|
Jun 14
2023
|
S. Dawn Smith |
BUY
Grant, award, or other acquisition
|
Direct |
17,864
+18.08%
|
-
|
|
Jun 14
2023
|
Mark B Templeton |
BUY
Grant, award, or other acquisition
|
Direct |
17,864
+20.37%
|
-
|
|
Jun 14
2023
|
Duncan Gallagher |
BUY
Grant, award, or other acquisition
|
Direct |
18,311
+15.62%
|
-
|
|
Jun 06
2023
|
Benjamin Landry General Counsel |
SELL
Open market or private sale
|
Direct |
1,078
-3.49%
|
$11,858
$11.84 P/Share
|
|
Jun 06
2023
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,370
-3.8%
|
$26,070
$11.84 P/Share
|
|
Jun 05
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
650
-0.27%
|
$7,800
$12.0 P/Share
|
|
Jun 01
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,433
-1.82%
|
$48,763
$11.24 P/Share
|
|
Jun 01
2023
|
Benjamin Landry General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
577
-1.83%
|
$6,347
$11.24 P/Share
|
|
Jun 01
2023
|
Anne Marie Bickmore COO and Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,755
-2.46%
|
$19,305
$11.24 P/Share
|
|
Jun 01
2023
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,066
-1.68%
|
$11,726
$11.24 P/Share
|
|
Jun 01
2023
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,411
-0.81%
|
$81,521
$11.24 P/Share
|
|
Jun 01
2023
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,038
-0.58%
|
$11,418
$11.24 P/Share
|
|
Jun 01
2023
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,548
-1.8%
|
$17,028
$11.24 P/Share
|
|
May 12
2023
|
Daniel D. Burton Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
49,050
+5.06%
|
$490,500
$10.19 P/Share
|
|
May 03
2023
|
Benjamin Landry General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+38.84%
|
-
|
|
May 03
2023
|
Anne Marie Bickmore COO and Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+32.93%
|
-
|